Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Visvikis-Siest

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Clinical Chemistry and Laboratory Medicine|July 8, 2008
The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseasesSophie Visvikis-Siest, Gérard Siest
Current Opinion in Lipidology|March 15, 2006
Genetic variants predisposing to cardiovascular diseaseSophie Visvikis-Siest, Jean-Brice Marteau
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 4, 2021
Integrating polymorphism signatures with myocardial perfusion imaging data to improve the prevention of coronary artery disease: Science or science-fiction?Pierre-Yves Marie, Sophie Visvikis-Siest
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 27, 2012
Genetic biomarkers of hypertension and future challenges integrating epigenomicsSaid El Shamieh, Sophie Visvikis-Siest
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 8, 2018
Do we need diagnostic strategies enhanced with genetic information for ischemic heart disease?Pierre-Yves Marie, Sophie Visvikis-Siest
Personalized Medicine|May 12, 2018
Beyond genome-wide association studies: identifying variants using -omics approachesSophie Visvikis-Siest, Maria G Stathopoulou
Pharmacogenomics|August 28, 2012
Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarinPayman Shahabi, Gérard Siest, Sophie Visvikis-Siest
Drug Metabolism Reviews|September 18, 2013
Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acidsPayman Shahabi, Gérard Siest, Sophie Visvikis-siest
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2007
Enzymes and pharmacogenetics of cardiovascular drugsGérard Siest, Elise Jeannesson, Sophie Visvikis-Siest
Pharmacogenomics|June 18, 2009
Personalized therapy and pharmacogenomics: future perspectiveGérard Siest, Jean-Brice Marteau, Sophie Visvikis-Siest
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Clinical Chemistry and Laboratory Medicine|July 8, 2008
The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseasesSophie Visvikis-Siest, Gérard Siest
Current Opinion in Lipidology|March 15, 2006
Genetic variants predisposing to cardiovascular diseaseSophie Visvikis-Siest, Jean-Brice Marteau
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 4, 2021
Integrating polymorphism signatures with myocardial perfusion imaging data to improve the prevention of coronary artery disease: Science or science-fiction?Pierre-Yves Marie, Sophie Visvikis-Siest
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 27, 2012
Genetic biomarkers of hypertension and future challenges integrating epigenomicsSaid El Shamieh, Sophie Visvikis-Siest
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 8, 2018
Do we need diagnostic strategies enhanced with genetic information for ischemic heart disease?Pierre-Yves Marie, Sophie Visvikis-Siest
Personalized Medicine|May 12, 2018
Beyond genome-wide association studies: identifying variants using -omics approachesSophie Visvikis-Siest, Maria G Stathopoulou
Pharmacogenomics|August 28, 2012
Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarinPayman Shahabi, Gérard Siest, Sophie Visvikis-Siest
Drug Metabolism Reviews|September 18, 2013
Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acidsPayman Shahabi, Gérard Siest, Sophie Visvikis-siest
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2007
Enzymes and pharmacogenetics of cardiovascular drugsGérard Siest, Elise Jeannesson, Sophie Visvikis-Siest
Pharmacogenomics|June 18, 2009
Personalized therapy and pharmacogenomics: future perspectiveGérard Siest, Jean-Brice Marteau, Sophie Visvikis-Siest
Pageof 15